Latest Regulatory Milestones News

Chariot Resources has secured Nigerian government approval for the transfer of six lithium licenses, marking a key step toward acquiring a majority stake in a promising Nigerian lithium portfolio. This regulatory milestone enables immediate exploration and mining activities at multiple projects amid soaring lithium prices.

Dimerix Limited has completed dosing of the last adult patient in its ACTION3 Phase 3 trial for DMX-200, exceeding its recruitment target and setting the stage for key regulatory milestones.

Tetratherix Limited has raised approximately $5 million to fast-track its Tutelix prostate spacer into pivotal clinical trials across Australia and the US, aiming to improve radiation therapy for prostate cancer patients.

South Harz Potash Limited has raised A$1.25 million to fund exploration at its newly licensed copper-gold projects in Sweden, signalling a strategic pivot towards critical minerals and a planned rebrand to Turnstone Resources.

Rhythm Biosciences has achieved a significant regulatory milestone with NATA accreditation for its ColoSTAT® blood-based colorectal cancer test, enabling its commercial rollout in Australia and strengthening reimbursement prospects.

The NSW Department of Planning and Environment has approved a six-year extension for the Dartbrook underground coal mine, pushing its operational horizon to 2033 despite ongoing financial administration challenges.

AKORA Resources has secured a 25-year mining permit for its high-grade Bekisopa iron ore project in Madagascar, marking a pivotal step from exploration to development and unlocking new financing and partnership opportunities.

Island Pharmaceuticals has entered a pivotal research agreement with USAMRIID and the Geneva Foundation to accelerate FDA approval of Galidesivir for Marburg Virus Disease, leveraging top-tier US biodefense expertise.

Control Bionics has secured a key regulatory milestone with its NeuroNode device now eligible for reimbursement under Germany’s statutory health insurance, paving the way for expanded European distribution.

Bio-Gene Technology Limited reports strong progress in toxicology studies for Flavocide, targeting its first regulatory submission in Australia by March 2027. This milestone sets the stage for global registrations of the novel insecticide with a new mode of action.

Maronan Metals has been granted a Mineral Development Licence for its Maronan Silver Project, marking a pivotal step toward mine readiness and enabling underground resource expansion.

Vysarn Limited has reported a record half-year financial performance for 1HFY26, with net profit before tax soaring 92% year-on-year. The company reaffirms its $20 million NPBT target for FY26, underpinned by strong growth across all business segments and strategic project progress.